Drug repurposing (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Drug repurposing" in Czech language version.

refsWebsite

Global rank Czech rank

20nih.gov

4^th place

8^th place

13worldcat.org

5^th place

3^rd place

12doi.org

2^nd place

4^th place

1springer.com

274^th place

174^th place

1nature.com

234^th place

72^nd place

doi.org

dx.doi.org

SLEIGH, Sara H.; BARTON, Cheryl L. Repurposing Strategies for Therapeutics. Pharmaceutical Medicine. 2010-06, roč. 24, čís. 3, s. 151–159. Dostupné online [cit. 2023-01-23]. ISSN 1178-2595. DOI 10.1007/BF03256811. (anglicky)
ASHBURN, Ted T.; THOR, Karl B. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery. 2004-08, roč. 3, čís. 8, s. 673–683. Dostupné online [cit. 2023-01-23]. ISSN 1474-1776. DOI 10.1038/nrd1468. (anglicky)
ROSA, Sandro G. Viveiros; SANTOS, Wilson C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 2020, roč. 44, s. e40. PMID: 32256547 PMCID: PMC7105280. Dostupné online [cit. 2023-01-23]. ISSN 1680-5348. DOI 10.26633/RPSP.2020.40. PMID 32256547.
OPREA, Tudor I.; BAUMAN, Julie E.; BOLOGA, Cristian G. Drug Repurposing from an Academic Perspective. Drug Discovery Today. Therapeutic Strategies. 2011, roč. 8, čís. 3–4, s. 61–69. PMID: 22368688 PMCID: PMC3285382. Dostupné online [cit. 2023-01-23]. ISSN 1740-6773. DOI 10.1016/j.ddstr.2011.10.002. PMID 22368688.
NABIROTCHKIN, Serguei; PELUFFO, Alex E.; RINAUDO, Philippe. Next-generation drug repurposing using human genetics and network biology. Current Opinion in Pharmacology. 2020-04, roč. 51, s. 78–92. PMID: 31982325. Dostupné online [cit. 2023-01-23]. ISSN 1471-4973. DOI 10.1016/j.coph.2019.12.004. PMID 31982325.
KING, Emily A.; DAVIS, J. Wade; DEGNER, Jacob F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics. 2019-12, roč. 15, čís. 12, s. e1008489. PMID: 31830040 PMCID: PMC6907751. Dostupné online [cit. 2023-01-23]. ISSN 1553-7404. DOI 10.1371/journal.pgen.1008489. PMID 31830040.
KALE, Vijay P.; HABIB, Hasan; CHITREN, Robert. Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology. 2021-01, roč. 68, s. 242–248. PMID: 32151704. Dostupné online [cit. 2023-01-23]. ISSN 1096-3650. DOI 10.1016/j.semcancer.2020.03.005. PMID 32151704.
KALE, Vijay Pralhad; AMIN, Shantu G.; PANDEY, Manoj K. Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochimica Et Biophysica Acta. 2015-10, roč. 1848, čís. 10 Pt B, s. 2747–2755. PMID: 25843679. Dostupné online [cit. 2023-01-23]. ISSN 0006-3002. DOI 10.1016/j.bbamem.2015.03.034. PMID 25843679.
GAMBINO, Dinorah; OTERO Á, Lucía. Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic. Metal Ions in Life Sciences. 2019-01-14, roč. 19, s. /books/9783110527872/9783110527872–019/9783110527872–019.xml. PMID: 30855114. Dostupné online [cit. 2023-01-23]. ISSN 1559-0836. DOI 10.1515/9783110527872-019. PMID 30855114.
FIRTH, Anton; PRATHAPAN, Praveen. Broad-spectrum therapeutics: A new antimicrobial class. Current Research in Pharmacology and Drug Discovery. 2021, roč. 2, s. 100011. PMID: 34870144 PMCID: PMC8035643. Dostupné online [cit. 2023-01-23]. ISSN 2590-2571. DOI 10.1016/j.crphar.2020.100011. PMID 34870144.
BARTOLI, Francesco; CAVALERI, Daniele; BACHI, Bianca. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. Journal of Psychiatric Research. 2021-11, roč. 143, s. 230–238. PMID: 34509090. Dostupné online [cit. 2023-01-23]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2021.09.018. PMID 34509090.
FAVA, Maurizio. The promise and challenges of drug repurposing in psychiatry. World psychiatry: official journal of the World Psychiatric Association (WPA). 2018-02, roč. 17, čís. 1, s. 28–29. PMID: 29352538 PMCID: PMC5775121. Dostupné online [cit. 2023-01-23]. ISSN 1723-8617. DOI 10.1002/wps.20481. PMID 29352538.

nature.com

ASHBURN, Ted T.; THOR, Karl B. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery. 2004-08, roč. 3, čís. 8, s. 673–683. Dostupné online [cit. 2023-01-23]. ISSN 1474-1776. DOI 10.1038/nrd1468. (anglicky)

nih.gov

pubmed.ncbi.nlm.nih.gov

ROSA, Sandro G. Viveiros; SANTOS, Wilson C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 2020, roč. 44, s. e40. PMID: 32256547 PMCID: PMC7105280. Dostupné online [cit. 2023-01-23]. ISSN 1680-5348. DOI 10.26633/RPSP.2020.40. PMID 32256547.
OPREA, Tudor I.; BAUMAN, Julie E.; BOLOGA, Cristian G. Drug Repurposing from an Academic Perspective. Drug Discovery Today. Therapeutic Strategies. 2011, roč. 8, čís. 3–4, s. 61–69. PMID: 22368688 PMCID: PMC3285382. Dostupné online [cit. 2023-01-23]. ISSN 1740-6773. DOI 10.1016/j.ddstr.2011.10.002. PMID 22368688.
NABIROTCHKIN, Serguei; PELUFFO, Alex E.; RINAUDO, Philippe. Next-generation drug repurposing using human genetics and network biology. Current Opinion in Pharmacology. 2020-04, roč. 51, s. 78–92. PMID: 31982325. Dostupné online [cit. 2023-01-23]. ISSN 1471-4973. DOI 10.1016/j.coph.2019.12.004. PMID 31982325.
KING, Emily A.; DAVIS, J. Wade; DEGNER, Jacob F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics. 2019-12, roč. 15, čís. 12, s. e1008489. PMID: 31830040 PMCID: PMC6907751. Dostupné online [cit. 2023-01-23]. ISSN 1553-7404. DOI 10.1371/journal.pgen.1008489. PMID 31830040.
KALE, Vijay P.; HABIB, Hasan; CHITREN, Robert. Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology. 2021-01, roč. 68, s. 242–248. PMID: 32151704. Dostupné online [cit. 2023-01-23]. ISSN 1096-3650. DOI 10.1016/j.semcancer.2020.03.005. PMID 32151704.
KALE, Vijay Pralhad; AMIN, Shantu G.; PANDEY, Manoj K. Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochimica Et Biophysica Acta. 2015-10, roč. 1848, čís. 10 Pt B, s. 2747–2755. PMID: 25843679. Dostupné online [cit. 2023-01-23]. ISSN 0006-3002. DOI 10.1016/j.bbamem.2015.03.034. PMID 25843679.
GAMBINO, Dinorah; OTERO Á, Lucía. Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic. Metal Ions in Life Sciences. 2019-01-14, roč. 19, s. /books/9783110527872/9783110527872–019/9783110527872–019.xml. PMID: 30855114. Dostupné online [cit. 2023-01-23]. ISSN 1559-0836. DOI 10.1515/9783110527872-019. PMID 30855114.
FIRTH, Anton; PRATHAPAN, Praveen. Broad-spectrum therapeutics: A new antimicrobial class. Current Research in Pharmacology and Drug Discovery. 2021, roč. 2, s. 100011. PMID: 34870144 PMCID: PMC8035643. Dostupné online [cit. 2023-01-23]. ISSN 2590-2571. DOI 10.1016/j.crphar.2020.100011. PMID 34870144.
BARTOLI, Francesco; CAVALERI, Daniele; BACHI, Bianca. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. Journal of Psychiatric Research. 2021-11, roč. 143, s. 230–238. PMID: 34509090. Dostupné online [cit. 2023-01-23]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2021.09.018. PMID 34509090.
FAVA, Maurizio. The promise and challenges of drug repurposing in psychiatry. World psychiatry: official journal of the World Psychiatric Association (WPA). 2018-02, roč. 17, čís. 1, s. 28–29. PMID: 29352538 PMCID: PMC5775121. Dostupné online [cit. 2023-01-23]. ISSN 1723-8617. DOI 10.1002/wps.20481. PMID 29352538.

ncbi.nlm.nih.gov

ROSA, Sandro G. Viveiros; SANTOS, Wilson C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 2020, roč. 44, s. e40. PMID: 32256547 PMCID: PMC7105280. Dostupné online [cit. 2023-01-23]. ISSN 1680-5348. DOI 10.26633/RPSP.2020.40. PMID 32256547.
OPREA, Tudor I.; BAUMAN, Julie E.; BOLOGA, Cristian G. Drug Repurposing from an Academic Perspective. Drug Discovery Today. Therapeutic Strategies. 2011, roč. 8, čís. 3–4, s. 61–69. PMID: 22368688 PMCID: PMC3285382. Dostupné online [cit. 2023-01-23]. ISSN 1740-6773. DOI 10.1016/j.ddstr.2011.10.002. PMID 22368688.
NABIROTCHKIN, Serguei; PELUFFO, Alex E.; RINAUDO, Philippe. Next-generation drug repurposing using human genetics and network biology. Current Opinion in Pharmacology. 2020-04, roč. 51, s. 78–92. PMID: 31982325. Dostupné online [cit. 2023-01-23]. ISSN 1471-4973. DOI 10.1016/j.coph.2019.12.004. PMID 31982325.
KING, Emily A.; DAVIS, J. Wade; DEGNER, Jacob F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics. 2019-12, roč. 15, čís. 12, s. e1008489. PMID: 31830040 PMCID: PMC6907751. Dostupné online [cit. 2023-01-23]. ISSN 1553-7404. DOI 10.1371/journal.pgen.1008489. PMID 31830040.
KALE, Vijay P.; HABIB, Hasan; CHITREN, Robert. Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology. 2021-01, roč. 68, s. 242–248. PMID: 32151704. Dostupné online [cit. 2023-01-23]. ISSN 1096-3650. DOI 10.1016/j.semcancer.2020.03.005. PMID 32151704.
KALE, Vijay Pralhad; AMIN, Shantu G.; PANDEY, Manoj K. Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochimica Et Biophysica Acta. 2015-10, roč. 1848, čís. 10 Pt B, s. 2747–2755. PMID: 25843679. Dostupné online [cit. 2023-01-23]. ISSN 0006-3002. DOI 10.1016/j.bbamem.2015.03.034. PMID 25843679.
GAMBINO, Dinorah; OTERO Á, Lucía. Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic. Metal Ions in Life Sciences. 2019-01-14, roč. 19, s. /books/9783110527872/9783110527872–019/9783110527872–019.xml. PMID: 30855114. Dostupné online [cit. 2023-01-23]. ISSN 1559-0836. DOI 10.1515/9783110527872-019. PMID 30855114.
FIRTH, Anton; PRATHAPAN, Praveen. Broad-spectrum therapeutics: A new antimicrobial class. Current Research in Pharmacology and Drug Discovery. 2021, roč. 2, s. 100011. PMID: 34870144 PMCID: PMC8035643. Dostupné online [cit. 2023-01-23]. ISSN 2590-2571. DOI 10.1016/j.crphar.2020.100011. PMID 34870144.
BARTOLI, Francesco; CAVALERI, Daniele; BACHI, Bianca. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. Journal of Psychiatric Research. 2021-11, roč. 143, s. 230–238. PMID: 34509090. Dostupné online [cit. 2023-01-23]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2021.09.018. PMID 34509090.
FAVA, Maurizio. The promise and challenges of drug repurposing in psychiatry. World psychiatry: official journal of the World Psychiatric Association (WPA). 2018-02, roč. 17, čís. 1, s. 28–29. PMID: 29352538 PMCID: PMC5775121. Dostupné online [cit. 2023-01-23]. ISSN 1723-8617. DOI 10.1002/wps.20481. PMID 29352538.

springer.com

link.springer.com

SLEIGH, Sara H.; BARTON, Cheryl L. Repurposing Strategies for Therapeutics. Pharmaceutical Medicine. 2010-06, roč. 24, čís. 3, s. 151–159. Dostupné online [cit. 2023-01-23]. ISSN 1178-2595. DOI 10.1007/BF03256811. (anglicky)

worldcat.org

SLEIGH, Sara H.; BARTON, Cheryl L. Repurposing Strategies for Therapeutics. Pharmaceutical Medicine. 2010-06, roč. 24, čís. 3, s. 151–159. Dostupné online [cit. 2023-01-23]. ISSN 1178-2595. DOI 10.1007/BF03256811. (anglicky)
ASHBURN, Ted T.; THOR, Karl B. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery. 2004-08, roč. 3, čís. 8, s. 673–683. Dostupné online [cit. 2023-01-23]. ISSN 1474-1776. DOI 10.1038/nrd1468. (anglicky)
ROSA, Sandro G. Viveiros; SANTOS, Wilson C. Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana De Salud Publica = Pan American Journal of Public Health. 2020, roč. 44, s. e40. PMID: 32256547 PMCID: PMC7105280. Dostupné online [cit. 2023-01-23]. ISSN 1680-5348. DOI 10.26633/RPSP.2020.40. PMID 32256547.
OPREA, Tudor I.; BAUMAN, Julie E.; BOLOGA, Cristian G. Drug Repurposing from an Academic Perspective. Drug Discovery Today. Therapeutic Strategies. 2011, roč. 8, čís. 3–4, s. 61–69. PMID: 22368688 PMCID: PMC3285382. Dostupné online [cit. 2023-01-23]. ISSN 1740-6773. DOI 10.1016/j.ddstr.2011.10.002. PMID 22368688.
NABIROTCHKIN, Serguei; PELUFFO, Alex E.; RINAUDO, Philippe. Next-generation drug repurposing using human genetics and network biology. Current Opinion in Pharmacology. 2020-04, roč. 51, s. 78–92. PMID: 31982325. Dostupné online [cit. 2023-01-23]. ISSN 1471-4973. DOI 10.1016/j.coph.2019.12.004. PMID 31982325.
KING, Emily A.; DAVIS, J. Wade; DEGNER, Jacob F. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS genetics. 2019-12, roč. 15, čís. 12, s. e1008489. PMID: 31830040 PMCID: PMC6907751. Dostupné online [cit. 2023-01-23]. ISSN 1553-7404. DOI 10.1371/journal.pgen.1008489. PMID 31830040.
KALE, Vijay P.; HABIB, Hasan; CHITREN, Robert. Old drugs, new uses: Drug repurposing in hematological malignancies. Seminars in Cancer Biology. 2021-01, roč. 68, s. 242–248. PMID: 32151704. Dostupné online [cit. 2023-01-23]. ISSN 1096-3650. DOI 10.1016/j.semcancer.2020.03.005. PMID 32151704.
KALE, Vijay Pralhad; AMIN, Shantu G.; PANDEY, Manoj K. Targeting ion channels for cancer therapy by repurposing the approved drugs. Biochimica Et Biophysica Acta. 2015-10, roč. 1848, čís. 10 Pt B, s. 2747–2755. PMID: 25843679. Dostupné online [cit. 2023-01-23]. ISSN 0006-3002. DOI 10.1016/j.bbamem.2015.03.034. PMID 25843679.
Drug repurposing and repositioning : workshop summary. Washington, D.C.: [s.n.] 1 online resource (xxii, 96 pages) s. Dostupné online. ISBN 978-0-309-30205-0, ISBN 0-309-30205-6. OCLC 893439616
GAMBINO, Dinorah; OTERO Á, Lucía. Metal Compounds in the Development of Antiparasitic Agents: Rational Design from Basic Chemistry to the Clinic. Metal Ions in Life Sciences. 2019-01-14, roč. 19, s. /books/9783110527872/9783110527872–019/9783110527872–019.xml. PMID: 30855114. Dostupné online [cit. 2023-01-23]. ISSN 1559-0836. DOI 10.1515/9783110527872-019. PMID 30855114.
FIRTH, Anton; PRATHAPAN, Praveen. Broad-spectrum therapeutics: A new antimicrobial class. Current Research in Pharmacology and Drug Discovery. 2021, roč. 2, s. 100011. PMID: 34870144 PMCID: PMC8035643. Dostupné online [cit. 2023-01-23]. ISSN 2590-2571. DOI 10.1016/j.crphar.2020.100011. PMID 34870144.
BARTOLI, Francesco; CAVALERI, Daniele; BACHI, Bianca. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. Journal of Psychiatric Research. 2021-11, roč. 143, s. 230–238. PMID: 34509090. Dostupné online [cit. 2023-01-23]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2021.09.018. PMID 34509090.
FAVA, Maurizio. The promise and challenges of drug repurposing in psychiatry. World psychiatry: official journal of the World Psychiatric Association (WPA). 2018-02, roč. 17, čís. 1, s. 28–29. PMID: 29352538 PMCID: PMC5775121. Dostupné online [cit. 2023-01-23]. ISSN 1723-8617. DOI 10.1002/wps.20481. PMID 29352538.